According to the FDA prescribing information for Wegovy (semaglutide 2.4 mg), eructation (burping) occurs in approximately 7% of patients
The lawsuits involve different medications, but they were centralized into the MDL because they share common questions of fact: Each lawsuit contains substantially similar allegations about GLP-1 RAs (specifically, Ozempic, Wegovy, Rybelsus, Trulicity, and/or Mounjaro) and their alleged propensity to cause gastrointestinal injuries. What Do Lawsuits Allege
Key results published in The Lancet Psychiatry: Both medications were safe & effective adjuncts Quetiapine was superior to lithium in improving symptoms over one year Quetiapine was more cost-effective for services & society Patients reported better functioning & quality of life Read more: Study site: Blog: Paper: Register for the free webinar (6 Oct): #DifficultToTreatDepression #TreatmentResistantDepression #Prescribing #MentalHealthResearch To view or add a comment, sign in For prescribers: The LQD study tested lithium vs quetiapine augmentation for treatment-resistant depression
As several novel evidence has offered, probiotics can be helpful in enhancing humans health as well as preventing the diseases or reducing their severity
"Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinking in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study." Nutrients , vol
A nuanced understanding of safe exposure thresholds and patient-specific susceptibility factors will be critical to ensure that EMF-based modalities do not inadvertently heighten the risk of secondary malignancies or other adverse outcomes
